Merck Company Stock Number Of Shares Shorted
| MRK Stock | EUR 145.30 0.05 0.03% |
Merck Company fundamentals help investors to digest information that contributes to Merck's financial success or failures. It also enables traders to predict the movement of Merck Stock. The fundamental analysis module provides a way to measure Merck's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Merck stock.
Merck |
Merck Company Company Number Of Shares Shorted Analysis
Merck's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
| Competition |
Based on the recorded statements, Merck Company has 0.0 of outstending shares currently sold short by investors. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. The number of shares shorted for all Germany stocks is 100.0% higher than that of the company.
Did you try this?
Run Correlation Analysis Now
Correlation AnalysisReduce portfolio risk simply by holding instruments which are not perfectly correlated |
| All Next | Launch Module |
Merck Fundamentals
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0656 | |||
| Profit Margin | 0.16 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 87.36 B | |||
| Shares Outstanding | 129.24 M | |||
| Shares Owned By Institutions | 60.26 % | |||
| Price To Earning | 36.46 X | |||
| Price To Book | 2.77 X | |||
| Price To Sales | 3.80 X | |||
| Revenue | 19.69 B | |||
| Gross Profit | 12.36 B | |||
| EBITDA | 5.96 B | |||
| Net Income | 3.06 B | |||
| Cash And Equivalents | 2.3 B | |||
| Cash Per Share | 5.29 X | |||
| Total Debt | 7.93 B | |||
| Debt To Equity | 0.65 % | |||
| Current Ratio | 1.00 X | |||
| Book Value Per Share | 64.91 X | |||
| Cash Flow From Operations | 4.62 B | |||
| Earnings Per Share | 7.99 X | |||
| Price To Earnings To Growth | 3.09 X | |||
| Target Price | 101.0 | |||
| Number Of Employees | 63.72 K | |||
| Beta | 0.65 | |||
| Market Capitalization | 73.82 B | |||
| Total Asset | 45.36 B | |||
| Z Score | 5.4 | |||
| Annual Yield | 0.01 % | |||
| Five Year Return | 1.21 % | |||
| Net Asset | 45.36 B | |||
| Last Dividend Paid | 1.85 |
About Merck Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Merck Company's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Merck using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Merck Company based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Merck Stock
When determining whether Merck Company is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Merck Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Merck Company Stock. Highlighted below are key reports to facilitate an investment decision about Merck Company Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.